Opinion: Imposter syndrome can lead to anxiety, depression, guilt
By Aparna S October 29, 2024: Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
By Aparna S October 29, 2024: Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their.
HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.
The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..
HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted.
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.
HQ Team, July 22, 2024: A study of over 22,000 airline crew members found that irregular and delayed meal times can lead to.
HQ Team July 19, 2024:A new study from Stanford has identified six new subtypes of depression known as “biotypes” using brain imaging with.
By Aparna S April 3, 2024: Over the last decade and until 2022 about one-third of India’s 1.4 billion people have become city.
By Aparna S March 26, 2024: With a high literacy rate, the migration rates in India’s southern state of Kerala have always been.
Bharti Jayshankar January 26, 2024: A recent UK-based BRIGhTMIND trial sheds light on the comparable effectiveness and safety of two advanced neuromodulation MRI.